An Unusual Presentation of Post-transplant Lymphoproliferative Disorder Mimicking Vasculitis in Heart Transplantation

David L. Murray, Naveen Luke Pereira, Dylan V. Miller

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This report details an unusual case of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) involving the epicardial coronary arteries and myocardial arterioles of an allograft heart, morphologically mimicking vasculitis, a finding associated with acute rejection, cardiac allograft vasculopathy (CAV), infection and infarction. Recognition of this novel PTLD pattern as a potential imitator of acute rejection in particular is important because reduction of immunosuppression (to treat PTLD) is antithetical to the usual therapy for rejection.

Original languageEnglish (US)
Pages (from-to)1257-1261
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume27
Issue number11
DOIs
StatePublished - Nov 2008

Fingerprint

Lymphoproliferative Disorders
Heart Transplantation
Vasculitis
Transplants
Allografts
Arterioles
Human Herpesvirus 4
Immunosuppression
Infarction
Coronary Vessels
Infection
Therapeutics

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

An Unusual Presentation of Post-transplant Lymphoproliferative Disorder Mimicking Vasculitis in Heart Transplantation. / Murray, David L.; Pereira, Naveen Luke; Miller, Dylan V.

In: Journal of Heart and Lung Transplantation, Vol. 27, No. 11, 11.2008, p. 1257-1261.

Research output: Contribution to journalArticle

@article{b2c388f015ba4380b192a8bfe6d06394,
title = "An Unusual Presentation of Post-transplant Lymphoproliferative Disorder Mimicking Vasculitis in Heart Transplantation",
abstract = "This report details an unusual case of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) involving the epicardial coronary arteries and myocardial arterioles of an allograft heart, morphologically mimicking vasculitis, a finding associated with acute rejection, cardiac allograft vasculopathy (CAV), infection and infarction. Recognition of this novel PTLD pattern as a potential imitator of acute rejection in particular is important because reduction of immunosuppression (to treat PTLD) is antithetical to the usual therapy for rejection.",
author = "Murray, {David L.} and Pereira, {Naveen Luke} and Miller, {Dylan V.}",
year = "2008",
month = "11",
doi = "10.1016/j.healun.2008.07.029",
language = "English (US)",
volume = "27",
pages = "1257--1261",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - An Unusual Presentation of Post-transplant Lymphoproliferative Disorder Mimicking Vasculitis in Heart Transplantation

AU - Murray, David L.

AU - Pereira, Naveen Luke

AU - Miller, Dylan V.

PY - 2008/11

Y1 - 2008/11

N2 - This report details an unusual case of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) involving the epicardial coronary arteries and myocardial arterioles of an allograft heart, morphologically mimicking vasculitis, a finding associated with acute rejection, cardiac allograft vasculopathy (CAV), infection and infarction. Recognition of this novel PTLD pattern as a potential imitator of acute rejection in particular is important because reduction of immunosuppression (to treat PTLD) is antithetical to the usual therapy for rejection.

AB - This report details an unusual case of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) involving the epicardial coronary arteries and myocardial arterioles of an allograft heart, morphologically mimicking vasculitis, a finding associated with acute rejection, cardiac allograft vasculopathy (CAV), infection and infarction. Recognition of this novel PTLD pattern as a potential imitator of acute rejection in particular is important because reduction of immunosuppression (to treat PTLD) is antithetical to the usual therapy for rejection.

UR - http://www.scopus.com/inward/record.url?scp=54249145043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249145043&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2008.07.029

DO - 10.1016/j.healun.2008.07.029

M3 - Article

C2 - 18971100

AN - SCOPUS:54249145043

VL - 27

SP - 1257

EP - 1261

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 11

ER -